Sep 8th, 2023 Your Fat Fighting Formula Introduction (Chapter 1) Discover the powerful synergy of maintaining a nutritional surplus, adopting a 5 net carb eating plan, prioritizing exercise, hydration, considering semaglutide, and quality sleep to optimize fat loss and achieve sustainable, transformative results
Hims & Hers executives say the current weight loss offering is tracking to eclipse $100 million in revenue by the end of 2025, growing faster than any specialty in the companys history
Growth is further supported by favorable regulatory approvals, expanded insurance coverage, and widespread physician adoption, making these treatments more accessible
Inspection Report Form FDA 483 issued June 10, 2025Types of Products Made: Sterile compounded drug products, including semaglutide injection and hormone health treatments sold to Hims & Hers Telehealth customers (see Essential Extras below)FDA Warning: MedisourceRx failed to submit adverse event reports to the FDA within the required timeframe